Get started
Live feed
·
INSIDERFilingvia Quantisnow
Lisata Therapeutics Inc. logo

Lisata Therapeutics (LSTA) director Azab received 19,480 shares

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Mohammad Azab (director at Lisata Therapeutics Inc., LSTA) reported that they received 19,480 shares on Jan 9, 2024. After these transactions the filing shows 58,680 shares held directly.

Reporting person
Azab Mohammad
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Jan 9, 2024Grant or award (A)Common Stock1, 2+19,480--58,680 direct

Holdings before and after

  • Common Stock: 39,200 to 58,680 direct

Footnotes from the filing

  1. 1. Represents 19,480 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2025.
  2. 2. Includes 32,280 unvested restricted stock units.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Azab report in this LSTA Form 4?

Mohammad Azab (director at Lisata Therapeutics Inc., LSTA) reported that they received 19,480 shares on Jan 9, 2024. After these transactions the filing shows 58,680 shares held directly.

How many LSTA shares does Azab hold after this filing?

The filing shows 58,680 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for LSTA

Earlier insider filings at LSTA

Quantisnow market dataNASDAQ
Lisata Therapeutics Inc. logo
LSTA
Lisata Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Get push alerts for LSTA

Follow LSTA and get a push notification the moment its next story breaks.

Full LSTA profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LSTA (Lisata Therapeutics Inc.) and more on Quantisnow.